Global Radiocontrast Agent Market Study 2016-2026, by Segment (Barium-based Radiocontrast Agent, Iodinated Radiocontrast Agent, … …), by Market (Radiology, Interventional Radiology, … …), by Company (GE Healthcare (US), Bracco Imaging (Italy)

SKU ID :99ST-14631756 | Published Date: 29-Oct-2019 | No. of pages: 54
Summary

The global Radiocontrast Agent market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):


Barium-based Radiocontrast Agent
Iodinated Radiocontrast Agent
Gadolinium-based Radiocontrast Agent
Microbubble Radiocontrast Agent
X-ray/Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Radiology
Interventional Radiology
Interventional Cardiology

Company Coverage (Sales data, Main Products & Services etc.):


GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)

Major Region

Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
  • PRICE
  • $1800
    $3600
    Buy Now

Our Clients